MATA NATHAN L. (Chief Scientific Officer) sold 11.5% of their position (1K shares) of BELITE BIO, INC on the open market
Open‑market sale worth $162.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 5 sales
Filed: 4/28/2026ACC: 0001193125-26-187224
Officer· Chief Scientific Officer
Since Mar 2026
-1K
Net shares
Net seller
$162.6K
Total sold
5
Open market trades
0B · 5S
5
Total transactions
1K disposed
Non-Derivative Transactions5
American depositary share
Direct
Shares
−44.00
Price / share
$160.83
Trade value
$7.08K
% of position
0.5%
4/27/2026
8.67K→8.62K
American depositary share
Direct
Shares
−280.00
Price / share
$161.62
Trade value
$45.25K
% of position
3.2%
4/27/2026
8.62K→8.34K
American depositary share
Direct
Shares
−231.00
Price / share
$162.38
Trade value
$37.51K
% of position
2.8%
4/27/2026
8.34K→8.11K
American depositary share
Direct
Shares
−409.00
Price / share
$163.56
Trade value
$66.89K
% of position
5.0%
4/27/2026
8.11K→7.70K
American depositary share
Direct
Shares
−36.00
Price / share
$164.07
Trade value
$5.91K
% of position
0.5%
4/27/2026
7.70K→7.67K
Total
Net shares
−1K
Net value
-$162.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American depositary share Direct | 4/27/2026 | S · Sale | −44.00 | $160.83 | $7.08K | 0.5% | 8.67K | 8.62K |
| American depositary share Direct | 4/27/2026 | S · Sale | −280.00 | $161.62 | $45.25K | 3.2% | 8.62K | 8.34K |
| American depositary share Direct | 4/27/2026 | S · Sale | −231.00 | $162.38 | $37.51K | 2.8% | 8.34K | 8.11K |
| American depositary share Direct | 4/27/2026 | S · Sale | −409.00 | $163.56 | $66.89K | 5.0% | 8.11K | 7.70K |
| American depositary share Direct | 4/27/2026 | S · Sale | −36.00 | $164.07 | $5.91K | 0.5% | 7.70K | 7.67K |
| Total | −1K | -$162.64K | ||||||
Derivative Transactions0
No derivative transactions reported